Compound Income
  • Blog
  • Scores
    • Scores Presentation
  • Portfolio
    • Table of Returns
  • Resources
    • Check list
  • About
  • Contact



Check up on healthy IT Stock...

14/3/2014

0 Comments

 
..with a sick looking share price.
Picture
This is an AIM listed stock with a market capitalization of £375 million which describes itself as the UK’s leading supplier of healthcare software to GP's and a major software supplier to high street pharmacies. I think this is interesting because GP's are getting bigger budgets and a greater role in healthcare provision and the government is also trying to make greater use of patient data to improve health outcomes and efficiency in the NHS, although I see there have been some delays to the roll out of this on privacy concerns. 

Their business provides a range of services across healthcare. This is broken down as follows:
Healthcare Record Systems
EMIS Web allows primary, secondary and community healthcare practitioners to view and contribute to a patient’s cradle-to-grave electronic healthcare record. This can improve patient care and increases efficiency. As at 30 June 2013 they had a UK GP market share of 52.4%. 
Pharmacy
RX Systems is a major supplier of software to pharmacists with a UK market share at 30 June 2013 of 34.9%. Their ProScript software is the most widely used community pharmacy dispensary management system in the UK, efficiently managing the dispensary process, labelling and endorsing patient records, ordering and stock control. 
Hardware
Egton specialises in the supply of ICT infrastructure, application software and value added services to healthcare and other public and private sector organisations.
Data Sharing
Healthcare Gateway facilitates the sharing of patient data via the medical interoperability gateway (MIG). EMIS IQ meets the demand for high quality clinical and management information to support the national General Practice Extraction Service (GPES).
Patient Services
Patient.co.uk is the leading independent health information and healthcare transactional site. It helps patients play a key part in their own care with an information library, health apps, on line and mobile services such as GP appointment booking and repeat prescription ordering.

Brief Highlights from Last years full year figures are:
Turnover £86.3 million with £69.4 million or 80.4% recurring and an operating profit of £22.8 million for an operating margin of 26.4%. They reported earnings of 30.76 pence and a dividend of 14.2 pence. They also did a couple of acquisitions last year (2013) spending £57.5 million and moved into a net debt position of £13.5 million at the year end having had net cash of £7.7 million at the end of 2012. These acquisitions were funded by a placing at 615 pence which raised £27 million and a new £32 million debt facility.

This year they are expected to report around 35 pence and a 16 pence dividend which is then forecast to rise to 39.7 pence and 17.6 pence which at the current price close to 600 pence leaves it on around a market rating of 15x with a 3% yield for the year to December 2014 growing at around mid teens rate. So it is certainly not cheap, but I think it looks quite good quality given that it supplies the healthcare industry, has high market shares and a high degree of recurring revenue. This is demonstrated by the return on capital employed (ROCE) of 31.3% and the operating margin of 26.4%. On Stockopedia it get a  98 on quality (100 is best). For an AIM stock it has quite good institutional backing with  Standard Life owning 9.4%, Schroders - 5.63%, Liontrust and Investec  around 5% each. In fact major shareholders make up around 69% of the shares so they are probably quite tightly held, although the share price momentum has been surprisingly poor.

Conclusion:
The reason for suggesting you check up on it now is that they have final results next week on 20th March, which could remind the market of its existence and maybe act as a catalyst to help turn around the depressed share price. Given the share price trend it will be interesting to see how the results are received and what they have to say about the outlook as they sounded pretty positive in the year end trading update in back in January when they said:

 "Trading for the year was in line with the Board's expectations with continued organic growth in revenues and profits together with positive contributions from the two acquisitions completed during the second half of the year.  The Group has continued to gain market share in each division during the period." They also mentioned progress being made with the renewal of the English GP Systems of Choice (GPSoC) Framework which is due to be concluded by 31 March 2014. This seems to be a contract that is up for grabs that EMIS is on the short list for, so I guess this could either be a positive or a negative depending on the outcome.

On this basis I have taken a small position as I like the quality and the value is OK, if not outstanding. Probably not one to rush out and buy but certainly worth watching I think, although I could be wrong.



0 Comments



Leave a Reply.

    RSS Feed

    Google+

    Archives

    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    June 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014

    Categories

    All
    32Red
    Aberdeen Am
    Admin
    A G Barr
    Alliance Pharma
    Alternative Telecoms
    AMEC
    Amino Technologies
    Amlin
    Anglo Pacific
    Asset Allocation
    Auto Trader Group
    BA Systems
    BATS
    Behavioural Finance
    Bellway
    Berendsen
    BHP Billiton
    Bloomsbury Publishing
    Bodycote
    Books
    Bovis Homes
    BREXIT
    Britvic
    Catlin-group
    Central Asia Metals
    Centrica
    Character Group
    Churchill China
    Cineworld
    City Of London Investment Group
    Clarkson
    Commercial Property
    Compound
    Computacenter
    Connect Group
    Croda
    Currencies
    Demographics
    Diageo
    Diploma
    Directors Dealings
    Dividends
    Easyjet
    Economics
    Emerging Markets
    Emis
    Empiric Student Property
    Etfs
    Fairpoint
    Ferguson
    Ferrexpo
    Finsbury Foods
    Food Retailers
    Forterra
    Games Workshop
    Gateley
    Go Compare
    Goid
    Greene King
    GSK
    Hargreaves Services
    Hays
    Headlam
    Hedge Funds
    Hill & Smith
    House Builders
    Howden
    HSBC
    IG Group
    Imperial Tobacco
    Indivor
    Inflation
    Insurance
    Intermediate Capital
    Interserve
    Investec
    Investment Trusts
    It
    ITV
    James Halstead
    Jarvis Investment Management
    JLT
    Jupiter Fund Management
    KCOM
    Kingfisher
    Legal & General
    Lloyds Bank
    Maintel
    Man Group
    Market Timing Indicator
    Market Valuation
    Marston's
    Matchtec
    Media
    Merlin Entertainment
    Micro Focus
    Mining
    Mitie
    Miton Group
    Moenysupermarket
    Mondi
    Moneysupermaket.com
    Music
    National Grid
    N.Brown
    News
    Next
    Nichols
    Norcros
    Oil
    Page Group
    Paypoint
    Pennon
    Persimmon
    Personal Finance
    Pharmaceuticals
    Phoenix Group
    Photo Me
    Photo-Me
    Plus500
    Podcasts
    Polar Capital
    Politics
    Portfolio
    Portmeirion
    Provident Financial
    PZC
    Qinetiq
    Ramsdens Holdings
    Rank Group
    Reckitt Benckiser
    Renewable Energy
    Renew Holdings
    Renishaw
    Research Papers
    Restaurant Group
    Retailers
    RIO
    RM Group
    Rolls Royce
    RPC
    RPS
    Safestore
    Sage
    Sainsburys
    Savills
    Schroders
    Scores
    SCS Group
    Sell Discipline
    Shareholder Yield
    Share Picks
    Short Interest
    Somero
    Spectris
    Sprue Aegis
    SSE
    Stock Spirits
    S & U Plc
    TalkTalk
    Taptica
    Tax
    Technology
    Telecoms
    Tobacco
    Trading Ideas
    TSB
    TUI
    UK Market Update
    Unilever
    Utilitywise
    Value
    Victrex
    Vodafone
    VP.
    Water Utilities
    Watkins Jones
    WH Smiths
    William Hill
    Wynstay
    XL Media
    XP Power
    Yield
    Zytronic

    googleda4a17cac6d02bb9.html
    File Size: 0 kb
    File Type: html
    Download File

Powered by Create your own unique website with customizable templates.
  • Blog
  • Scores
    • Scores Presentation
  • Portfolio
    • Table of Returns
  • Resources
    • Check list
  • About
  • Contact